Ameritas Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.16M Buy
25,182
+50
+0.2% +$11.6K 0.19% 80
2025
Q4
$5.2M Sell
25,132
-261
-1% -$51.6K 0.16% 102
2025
Q3
$4.71M Sell
25,393
-753
-3% -$129K 0.14% 114
2025
Q2
$3.99M Sell
26,146
-358
-1% -$55K 0.13% 137
2025
Q1
$4.4M Buy
26,504
+40
+0.2% +$6.26K 0.15% 103
2024
Q4
$3.83M Sell
26,464
-1,368
-5% -$212K 0.12% 134
2024
Q3
$4.51M Buy
27,832
+195
+0.7% +$31.1K 0.15% 112
2024
Q2
$4.04M Sell
27,637
-724
-3% -$108K 0.14% 124
2024
Q1
$4.49M Sell
28,361
-684
-2% -$109K 0.15% 108
2023
Q4
$4.55M Sell
29,045
-1,132
-4% -$174K 0.17% 89
2023
Q3
$4.7M Sell
30,177
-9,237
-23% -$1.52M 0.19% 79
2023
Q2
$6.52M Sell
39,414
-649
-2% -$105K 0.25% 54
2023
Q1
$6.21M Buy
40,063
+52
+0.1% +$8.4K 0.25% 56
2022
Q4
$6.8M Sell
40,011
-775
-2% -$134K 0.27% 55
2022
Q3
$6.66M Sell
40,786
-1,245
-3% -$211K 0.3% 47
2022
Q2
$7.46M Sell
42,031
-3,541
-8% -$631K 0.32% 40
2022
Q1
$8.08M Sell
45,572
-2,826
-6% -$481K 0.29% 44
2021
Q4
$8.28M Sell
48,398
-817
-2% -$134K 0.28% 50
2021
Q3
$7.95M Sell
49,215
-643
-1% -$110K 0.29% 49
2021
Q2
$8.21M Buy
49,858
+993
+2% +$164K 0.29% 41
2021
Q1
$7.96M Sell
48,865
-1,945
-4% -$315K 0.3% 42
2020
Q4
$8M Sell
50,810
-2,786
-5% -$411K 0.37% 32
2020
Q3
$7.98M Sell
53,596
-2,430
-4% -$360K 0.36% 34
2020
Q2
$7.88M Sell
56,026
-372
-0.7% -$54.2K 0.38% 34
2020
Q1
$7.39M Sell
56,398
-1,829
-3% -$259K 0.42% 32
2019
Q4
$8.49M Sell
58,227
-3,695
-6% -$501K 0.38% 33
2019
Q3
$8.01M Sell
61,922
-1,454
-2% -$192K 0.37% 35
2019
Q2
$8.83M Sell
63,376
-1,593
-2% -$221K 0.4% 33
2019
Q1
$9.08M Sell
64,969
-335
-0.5% -$44.9K 0.42% 25
2018
Q4
$8.43M Sell
65,304
-1,145
-2% -$160K 0.46% 22
2018
Q3
$9.18M Sell
66,449
-1,645
-2% -$219K 0.42% 21
2018
Q2
$8.26M Sell
68,094
-5,386
-7% -$672K 0.4% 22
2018
Q1
$9.42M Sell
73,480
-2,452
-3% -$331K 0.45% 21
2017
Q4
$10.3M Sell
75,932
-4,221
-5% -$588K 0.47% 24
2017
Q3
$10.6M Hold
80,153
0.5% 21
2017
Q2
$10.6M Sell
80,153
-2,076
-3% -$265K 0.51% 20
2017
Q1
$10.2M Sell
82,229
-3,160
-4% -$377K 0.51% 20
2016
Q4
$9.84M Buy
85,389
+2,218
+3% +$256K 0.49% 25
2016
Q3
$9.82M Buy
83,171
+14,286
+21% +$1.73M 0.53% 21
2016
Q2
$8.35M Buy
68,885
+14,817
+27% +$1.68M 0.54% 24
2016
Q1
$5.85M Buy
54,068
+281
+0.5% +$29.1K 0.39% 42
2015
Q4
$5.52M Buy
53,787
+470
+0.9% +$47.3K 0.37% 47
2015
Q3
$4.98M Hold
53,317
0.36% 46
2015
Q2
$5.2M Sell
53,317
-26,900
-34% -$2.69M 0.34% 50
2015
Q1
$8.07M Buy
80,217
+15,861
+25% +$1.61M 0.53% 26
2014
Q4
$6.73M Buy
64,356
+11,990
+23% +$1.26M 0.46% 33
2014
Q3
$5.58M Sell
52,366
-3,235
-6% -$336K 0.4% 41
2014
Q2
$5.82M Sell
55,601
-481
-0.9% -$48.6K 0.42% 37
2014
Q1
$5.51M Sell
56,082
-14,794
-21% -$1.37M 0.43% 40
2013
Q4
$6.49M Sell
70,876
-360
-0.5% -$33.2K 0.52% 31
2013
Q3
$6.17M Buy
71,236
+59,736
+519% +$5.36M 0.58% 18
2013
Q2
$987K Buy
+11,500
New +$976K 0.27% 160

Other funds holding JNJ

Ameritas Investment Partners's JNJ Position: Q1 2026 in Review

Ameritas Investment Partners increased its Johnson & Johnson (JNJ) stake by 0.2% in Q1 2026, buying an estimated $11.6K and bringing the position to 25,182 shares worth $6.16M. The position accounts for 0.19% of the portfolio, ranked #80.

Ameritas Investment Partners first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.6M in Q2 2017. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Ameritas Investment Partners held 25,182 shares of Johnson & Johnson worth $6.16M as of Q1 2026.
  • Ameritas Investment Partners bought 50 Johnson & Johnson shares in Q1 2026, an estimated $11.6K.
  • Johnson & Johnson made up 0.19% of Ameritas Investment Partners's portfolio in Q1 2026, its #80 holding.
  • Ameritas Investment Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Ameritas Investment Partners's Johnson & Johnson position peaked at $10.6M in Q2 2017.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.